Nurse Practitioner · Las Cruces, NM
NPI
1134628563
Since 2018
Specialty
Nurse Practitioner
Code 172V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6202 Alchemy St
Las Cruces, NM, 88012
Phone (575) 520-2824
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.2M
6,518 prescriptions
Company payments, 2025
$76K
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Victor L Ilog prescribed most often to Medicare patients was Quetiapine Fumarate, with 348 prescriptions and refills. In total Victor L Ilog wrote 6,518 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Quetiapine Fumarate Generic | 348 | 597 | 66 | $7,721 |
| Buspirone Hcl Generic | 318 | 641 | 90 | $7,177 |
| Clonazepam Generic | 285 | 291 | 38 | $3,697 |
| Divalproex Sodium Er Divalproex Sodium | 274 | 360 | 40 | $21K |
| Trazodone Hcl Generic | 273 | 489 | 53 | $2,625 |
| Sertraline Hcl Generic | 219 | 426 | 52 | $1,611 |
| Olanzapine Generic | 211 | 309 | 41 | $8,207 |
| Escitalopram Oxalate Generic | 206 | 390 | 40 | $1,617 |
| Aripiprazole Generic | 203 | 394 | 50 | $28K |
| Bupropion Xl Bupropion Hcl | 191 | 459 | 51 | $5,279 |
| Rexulti Brexpiprazole | 184 | 192 | 39 | $296K |
| Zolpidem Tartrate Generic | 172 | 172 | 28 | $1,125 |
| Mirtazapine Generic | 171 | 343 | 41 | $3,423 |
| Oxcarbazepine Generic | 169 | 235 | 25 | $13K |
| Risperidone Generic | 161 | 257 | 27 | $2,552 |
Brand drugs: - claims; generic drugs: 5,554 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor L Ilog $76K ($76K in general payments such as food, travel and fees) from 13 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 52 | $30K |
| Neurocrine BioSciences, Inc. NBIX | 23 | $14K |
| Alkermes, Inc. ALKS | 29 | $14K |
| Abbvie Inc. ABBV | 35 | $12K |
| Teva Pharmaceuticals USA, Inc. TEVA | 11 | $5,201 |
| Corium, LLC | 11 | $211 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 3 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $61.65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $53.34 |
| Lundbeck LLC | 1 | $25.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.